352 related articles for article (PubMed ID: 11558682)
21. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.
Hülsmann M; Berger R; Sturm B; Bojic A; Woloszczuk W; Bergler-Klein J; Pacher R
Eur Heart J; 2002 Jun; 23(11):886-91. PubMed ID: 12042010
[TBL] [Abstract][Full Text] [Related]
22. Roles of atrial natriuretic peptide and its therapeutic use.
Saito Y
J Cardiol; 2010 Nov; 56(3):262-70. PubMed ID: 20884176
[TBL] [Abstract][Full Text] [Related]
23. Discovery of a natriuretic peptide family and their clinical application.
Matsuo H
Can J Physiol Pharmacol; 2001 Aug; 79(8):736-40. PubMed ID: 11558683
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in natriuretic peptides in congestive heart failure.
Boerrigter G; Burnett JC
Expert Opin Investig Drugs; 2004 Jun; 13(6):643-52. PubMed ID: 15174950
[TBL] [Abstract][Full Text] [Related]
25. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
Davis ME; Richards AM; Nicholls MG; Yandle TG; Frampton CM; Troughton RW
Circulation; 2006 Feb; 113(7):977-85. PubMed ID: 16476851
[TBL] [Abstract][Full Text] [Related]
26. Mechanical and neuroendocrine regulation of the endocrine heart.
de Bold AJ; Bruneau BG; Kuroski de Bold ML
Cardiovasc Res; 1996 Jan; 31(1):7-18. PubMed ID: 8849584
[TBL] [Abstract][Full Text] [Related]
27. The physiological and pathophysiological modulation of the endocrine function of the heart.
de Bold AJ; Ma KK; Zhang Y; de Bold ML; Bensimon M; Khoshbaten A
Can J Physiol Pharmacol; 2001 Aug; 79(8):705-14. PubMed ID: 11558679
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.
Batlle M; Roig E; Perez-Villa F; Lario S; Cejudo-Martin P; García-Pras E; Ortiz J; Roqué M; Orús J; Rigol M; Heras M; Ramírez J; Jimenez W
J Heart Lung Transplant; 2006 Sep; 25(9):1117-25. PubMed ID: 16962475
[TBL] [Abstract][Full Text] [Related]
29. The natriuretic peptides in cardiovascular medicine.
Munagala VK; Burnett JC; Redfield MM
Curr Probl Cardiol; 2004 Dec; 29(12):707-69. PubMed ID: 15550914
[TBL] [Abstract][Full Text] [Related]
30. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review.
Woods RL
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):791-4. PubMed ID: 15566395
[TBL] [Abstract][Full Text] [Related]
31. [Natriuretic peptides: physiological, pathophysiological and clinical aspects].
Michels P; Tarnow J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):406-16. PubMed ID: 11496615
[TBL] [Abstract][Full Text] [Related]
32. [Natriuretic peptides--new diagnostic markers in heart disease].
Angermann CE; Ertl G
Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
[TBL] [Abstract][Full Text] [Related]
33. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
34. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
[TBL] [Abstract][Full Text] [Related]
35. Mechanical load-induced alterations in B-type natriuretic peptide gene expression.
Tokola H; Hautala N; Marttila M; Magga J; Pikkarainen S; Kerkelä R; Vuolteenaho O; Ruskoaho H
Can J Physiol Pharmacol; 2001 Aug; 79(8):646-53. PubMed ID: 11558673
[TBL] [Abstract][Full Text] [Related]
36. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
[TBL] [Abstract][Full Text] [Related]
37. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].
Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M
Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251
[TBL] [Abstract][Full Text] [Related]
38. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].
Mazurek W; Salomon P
Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795
[TBL] [Abstract][Full Text] [Related]
39. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the endocrine function of the heart in humans: proposal for an integrated approach for the assessment of production, secretion, distribution and degradation of atrial natriuretic factor and related peptides.
Clerico A; Iervasi G; Iascone MR; Manfredi C; Sabatino L; Bertelli A; Iascone MR; Bertelli AA
Int J Clin Pharmacol Res; 1995; 15(2):65-86. PubMed ID: 8593975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
